...
首页> 外文期刊>The Journal of rheumatology >Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
【24h】

Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.

机译:与全髋关节置换植入物的无菌性松动相关的溶骨相关的ADAM 12(meltrin-alpha)的表达和加工增加。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess the expression and processing of a disintegrin and metalloproteinase, ADAM 12 (meltrin-alpha), in the formation of multinuclear cells. Methods. In situ hybridization, immunohistochemical staining, and Western blotting of interface membrane around loosened total hip replacement implants. Macrophage-colony stimulating factor (M-CSF) and receptor activator of nuclear factor-kappaB ligand (RANKL) costimulation of human monocytes followed by FACS, immunofluorescence staining, Western blotting, and bone resorption assay. RESULTS: ADAM 12 mRNA-containing mononuclear cells were often seen in a close spatial relationship with ADAM 12-positive multinuclear cells. Morphometric analysis of ADAM 12 disclosed that 53% +/- 2% of all interface cells were ADAM 12-positive compared to 5% +/- 1% in controls (p < 0.001). M-CSF and RANKL were richly present in interface tissue around loosening implants. Upon M-CSF and RANKL costimulation of human monocytes in vitro, the ADAM 12 staining pattern changedover time, and ADAM 12-positive cells formed large mono-, bi-, and multinuclear cells at Day 7 and many multinuclear giant cells and/or osteoclasts at Day 14. Western blot disclosed 90 kDa latent ADAM 12L but also the metalloproteinase-cleaved, fusion-active 60 kDa form transiently just before the burst of fusion. CONCLUSION: ADAM 12, well recognized for participation in cell-cell fusion in myoblast formation, is upregulated and processed upon formation of multinuclear giant cells and osteoclasts. It may play a role in formation of giant cells and osteoclasts around loosened total hip replacement implants.
机译:目的:评估整合素和金属蛋白酶ADAM 12(meltrin-alpha)在多核细胞形成中的表达和加工。方法。原位杂交,免疫组织化学染色和松动的全髋关节置换植入物周围界面膜的蛋白质印迹。巨噬细胞集落刺激因子(M-CSF)和核因子-κB配体(RANKL)的受体激活剂共同刺激人单核细胞,然后进行FACS,免疫荧光染色,蛋白质印迹和骨吸收测定。结果:经常看到含ADAM 12 mRNA的单核细胞与ADAM 12阳性的多核细胞具有紧密的空间关系。 ADAM 12的形态计量分析显示,所有界面细胞的53%+/- 2%为ADAM 12阳性,而对照组为5%+/- 1%(p <0.001)。 M-CSF和RANKL大量存在于松动植入物周围的界面组织中。在体外对人单核细胞进行M-CSF和RANKL共刺激后,ADAM 12染色模式随时间变化,ADAM 12阳性细胞在第7天形成大的单核,双核和多核细胞,以及许多多核巨细胞和/或破骨细胞在第14天,Western blot揭示了90kDa潜在的ADAM 12L,但也有金属蛋白酶切割的,具有融合活性的60kDa形式,在融合破裂之前即刻发生。结论:ADAM 12,在成肌细胞形成中参与细胞-细胞融合而广为人知,在多核巨细胞和破骨细胞形成后被上调和加工。它可能在松动的全髋关节置换植入物周围形成巨细胞和破骨细胞中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号